Sherwyn Pharmaceuticals Private Limited
About Sherwyn Pharmaceuticals Private Limited
Data last updated:
Sherwyn Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 21 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51900TG2018PTC122402. Its GSTIN is 36AAZCS8672A1ZQ (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhu Derangula and Naren Sai Varikuppala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.61 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.74 Lakh (net margin 5.2%) and EBITDA of ₹10.15 Lakh (EBITDA margin 19.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
Company details
Contact details
Sherwyn Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH No 10 – 1 – 96/4/A B C D Durga Nagar Colony Lingojiguda Village Saroornagar Revenue, Mandal, Hyderabad, Telangana, India – 500035
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Sherwyn Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sherwyn Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sherwyn Pharmaceuticals Private Limited, buy the company report.
Financials of Sherwyn Pharmaceuticals Private Limited
FY 2024 filings availableSherwyn Pharmaceuticals Private Limited reported revenue of ₹52.61 Lakh (up 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 29% growth in the latest year. EBITDA rose 177% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.3% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sherwyn Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sherwyn Pharmaceuticals Private Limited
Sherwyn Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Derangula | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Naren Sai Varikuppala | Director | 21 Feb 2018 | 8 Years 8 Months | Current |
| Sreenivasa Rao Pallapu Also directs: Dr.Netra Pharmaceuticals Private Limited, Credible Health Care Private Limited, Vision Eye Crafts Hyd Private Limited and 2 more | Additional Director | 22 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Sherwyn Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wits Biotech Private Limited | ₹52.64 Lakh (FY 2024) | 9.0% | Chandigarh, India | |||
| Allbless Pharmaceuticals Private Limited | ₹52.62 Lakh (FY 2025) | 39.0% | Ahmedabad, Gujarat, India | |||
| Ontario Organics Private Limited | ₹52.62 Lakh (FY 2019) | -23.0% | Ahmedabad, Gujarat, India | |||
| Sherwyn Pharmaceuticals Private Limitedthis company | ₹52.61 Lakh (FY 2024) | ₹2.74 Lakh | 5.2% | 29.0% | Hyderabad, Telangana, India | |
| Qualtra Pharmaceuticals Private Limited | ₹52.54 Lakh (FY 2024) | -6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sherwyn Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sherwyn Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sherwyn Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sherwyn Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAZCS8672A1ZQ | Telangana | Active | 19 Apr 2018 |
To see the full GST registrations and return filing status of Sherwyn Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sherwyn Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Sreenivasa Rao Pallapu was appointed as Additional Director on 22 Apr 2024.
Frequently asked questions
Sherwyn Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 21 February 2018 (8+ years old) and is registered under CIN U51900TG2018PTC122402.
Sherwyn Pharmaceuticals has 3 current directors:
- Madhu Derangula - Director
- Naren Sai Varikuppala - Director
- Sreenivasa Rao Pallapu - Additional Director
The latest financial statements of Sherwyn Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sherwyn Pharmaceuticals is 36AAZCS8672A1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Sherwyn Pharmaceuticals is U51900TG2018PTC122402. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sherwyn Pharmaceuticals was incorporated on 21 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sherwyn Pharmaceuticals by revenue are Wits Biotech Private Limited, Allbless Pharmaceuticals Private Limited, Ontario Organics Private Limited, Qualtra Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sreenivasa Rao Pallapu was appointed as Additional Director on 22 Apr 2024. Madhu Derangula was appointed as Director on 01 Apr 2024. Sateesh Yandra ceased to be Director on 01 Apr 2024. Sherwyn Pharmaceuticals has 5 board changes on record in total.
The registered office of Sherwyn Pharmaceuticals is at H No 10 – 1 – 964A B C D Durga Nagar Colony Lingojiguda Village Saroornagar Revenue, Mandal, Hyderabad, Telangana, India – 500035.
Sherwyn Pharmaceuticals operates in the trading industry, in the specialty segment.
Sherwyn Pharmaceuticals can be reached at its registered office: H No 10 – 1 – 964A B C D Durga Nagar Colony Lingojiguda Village Saroornagar Revenue, Mandal, Hyderabad, Telangana, India – 500035.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
